書籍情報から探す
新潟県における肺がんの解析
Efficacy and Tolerability of the Bevacizumab/carboplatin/paclitaxel Combination Therapy as First-line or Non-first-line Therapy for Non-small-cell Lung Cancer
Makoto Nakashima*1,*2, Ryoko Ohnishi*3, Mizuho Kobayashi*3, Toshitaka Suzuki*3, Shigeo Yasuda*3, Kimiyasu Sano*3, Takuya Goto*1, Nobuyuki Mishima*1, Tatsuo Kato*3, Tadashi Sugiyama*2
*1Department of Pharmacy, Nagara Medical Center, *2Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University, *3Department of Respiratory Medicine, Nagara Medical Center
Japanese Journal of Lung Cancer 52 (7) 1007-1016, 2012.
*1Department of Pharmacy, Nagara Medical Center, *2Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University, *3Department of Respiratory Medicine, Nagara Medical Center
Japanese Journal of Lung Cancer 52 (7) 1007-1016, 2012.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。